about
Production of plasma-derived medicinal products: ethical implications for blood donation and donorsIs self-sufficiency in haemotherapies a practical or necessary goal?Cost effectiveness of Iran national plasma contract fractionation program.Implementation of Plasma Fractionation in Biological Medicines Production
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Plasma-derived medicines: access and usage issues
@ast
Plasma-derived medicines: access and usage issues
@en
type
label
Plasma-derived medicines: access and usage issues
@ast
Plasma-derived medicines: access and usage issues
@en
prefLabel
Plasma-derived medicines: access and usage issues
@ast
Plasma-derived medicines: access and usage issues
@en
P2860
P356
P1476
Plasma-derived medicines: access and usage issues
@en
P2093
Josephine Cassar
P2860
P304
P356
10.2450/2011.0118-11
P577
2012-07-01T00:00:00Z